Equity Market Microstructure: Taking Stock of What We Know

被引:1
|
作者
Francioni, Reto [1 ]
Hazarika, Sonali [2 ]
Reck, Martin [1 ]
Schwartz, Robert A. [2 ]
机构
[1] Deutsch Borse, Frankfurt, Germany
[2] CUNY, Baruch Coll, Zicklin Sch Business, New York, NY 10021 USA
来源
JOURNAL OF PORTFOLIO MANAGEMENT | 2008年 / 35卷 / 01期
关键词
D O I
10.3905/JPM.2008.35.1.57
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
For over three decades, the microstructure literature has grown and trading systems around the world have been reengineered into modern electronic platforms. In this article, the authors consider these developments, concentrating on microstructure issues that are germane to equity market architecture, and focus on the design of one trading facility, Deutsche B?'s Xetra. Important insights were gained from the microstructure literature during Xetra's planning period (1994?1997), and Xetra's implementation has marked a huge step forward for Germany's equity markets. Nevertheless, academic research and the design of a real-world marketplace remain works in progress.
引用
收藏
页码:57 / +
页数:16
相关论文
共 50 条
  • [41] Vitamin A and preterm infants: what we know, what we don't know, and what we need to know
    Mactier, H
    Weaver, LT
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2005, 90 (02): : 103 - 108
  • [42] Organizational unlearning as a process: What we know, what we don't know, what we should know
    Klammer, Adrian
    Grisold, Thomas
    Nguyen, Nhien
    Hsu, Shih-wei
    MANAGEMENT REVIEW QUARTERLY, 2024,
  • [43] FROM TINNITUS TO MISOPHONIA: WHAT WE KNOW, WHAT WE DON'T KNOW, AND WHAT WE SHOULD KNOW
    Dobel, Christian
    Keil, Andreas
    PSYCHOPHYSIOLOGY, 2024, 61 : S73 - S73
  • [44] TAKING STOCK IN ETHNOBIOLOGY: WHERE DO WE COME FROM? WHAT ARE WE? WHERE ARE WE GOING?
    Wyndham, Felice S.
    Lepofsky, Dana
    Tiffany, Sara
    JOURNAL OF ETHNOBIOLOGY, 2011, 31 (01) : 110 - 127
  • [46] Population and consumption - What we know, what we need to know
    Kates, RW
    ENVIRONMENT, 2000, 42 (03): : 10 - 19
  • [47] Outcomes in CKD: What We Know and What We Need to Know
    Clark, Laura E.
    Khan, Izhar
    NEPHRON CLINICAL PRACTICE, 2010, 114 (02): : C95 - C102
  • [48] CIGUATERA - WHAT WE KNOW AND WHAT WE WOULD LIKE TO KNOW
    SCHEUER, PJ
    MYCOTOXINS AND PHYCOTOXINS 88, 1989, 10 : 265 - 276
  • [49] Newborn screening conditions: What we know, what we do not know, and how we will know it
    Levy, Harvey L.
    GENETICS IN MEDICINE, 2010, 12 (12) : S213 - S214
  • [50] COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
    Dhawan, Rahul
    Gundry, Rebekah L.
    Brett-Major, David M.
    Mahr, Claudius
    Thiele, Geoffrey M.
    Lindsey, Merry L.
    Anderson, Daniel R.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 144 : 12 - 14